{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:57:23Z","timestamp":1771005443145,"version":"3.50.1"},"reference-count":16,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/mco.2016.805","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T09:26:59Z","timestamp":1457342819000},"page":"749-755","source":"Crossref","is-referenced-by-count":15,"title":["Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China"],"prefix":"10.3892","volume":"4","author":[{"given":"YUN","family":"CHEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIJUAN","family":"YE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REBECCA RONGRONG","family":"STANFORD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DONGFANG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XINGSONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WANLI","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"key20180107145729_b1-mco-0-0-805","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180107145729_b2-mco-0-0-805","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"key20180107145729_b3-mco-0-0-805","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1200\/JCO.2012.45.9867","article-title":"Lessons learned from lung cancer genomics: The emerging concept of individualized diagnostics and treatment","volume":"31","author":"Buettner","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107145729_b4-mco-0-0-805","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.10194","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): Simple drugs with a complex mechanism of action?","volume":"194","author":"Normanno","year":"2003","journal-title":"J Cell Physiol"},{"key":"key20180107145729_b5-mco-0-0-805","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"North-East Japan Study Group: Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107145729_b6-mco-0-0-805","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Spanish Lung Cancer Group in collaboration with Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie and Associazione Italiana Oncologia Toracica: Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20180107145729_b7-mco-0-0-805","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.rmed.2013.08.018","article-title":"Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning","volume":"107","author":"Hosgood","year":"2013","journal-title":"Respir Med"},{"key":"key20180107145729_b8-mco-0-0-805","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.21496","article-title":"Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers","volume":"118","author":"Shigematsu","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107145729_b9-mco-0-0-805","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1200\/JCO.2010.29.6038","article-title":"Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases","volume":"28","author":"Sun","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107145729_b10-mco-0-0-805","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/cncr.24181","article-title":"University of Hong Kong Lung Cancer Study Group: The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS","volume":"115","author":"Wong","year":"2009","journal-title":"Cancer"},{"key":"key20180107145729_b11-mco-0-0-805","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"key20180107145729_b12-mco-0-0-805","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-08-3248","article-title":"KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer","volume":"15","author":"Takeuchi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107145729_b13-mco-0-0-805","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/labinvest.2013.147","article-title":"Epidermal growth factor receptor mutations in lung adenocarcinoma","volume":"94","author":"Siegelin","year":"2014","journal-title":"Lab Invest"},{"key":"key20180107145729_b14-mco-0-0-805","doi-asserted-by":"crossref","first-page":"e110617","DOI":"10.1371\/journal.pone.0110617","article-title":"Clinicopathologic features of patients with non-small cell lung cancer harboring the EML4-ALK fusion gene: A meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"key20180107145729_b15-mco-0-0-805","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u2018never smokers\u2019 and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107145729_b16-mco-0-0-805","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.805\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:57:38Z","timestamp":1515337058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,7]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/mco.2016.805"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.805","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}